© 2023 KLCC

136 W 8th Ave
Eugene OR 97401

Contact Us

FCC Applications
Oregon's Willamette Valley seen from Eugene
NPR for Oregonians
Play Live Radio
Next Up:
Available On Air Stations

WATCH: Harvard-NPR panel on the fight to tame COVID

A livestreamed panel discussion involving Harvard T.H. Chan School of Public Health and NPR will include updates on COVID-19 vaccines for children, as well as other pressing issues affecting the course of the pandemic.
Harvard T.H. Chan School of Public Health

The world is approaching the second anniversary of a cluster of cases of respiratory illness traced to the Huanan Seafood Market in Wuhan, China, in December 2019. The cause: a virus we now know as SARS-CoV-2.

The World Health Organization named the illness caused by the virus COVID-19 in February 2020, as cases mounted in China and began spreading elsewhere.

Where are we now in the COVID-19 pandemic and where are we headed?

A panel of experts convened by NPR and the Harvard T.H. Chan School of Public Health will discuss the latest developments and challenges during a live-streamed event from noon to 1 p.m. on Friday.

Register for free to join the discussion.

Email your questions for the speakers.

Panel lineup

Scott Hensley, senior health editor on NPR's Science Desk, will moderate the discussion featuring:

Kizzmekia Corbett, assistant professor of immunology and infectious diseases, Harvard T.H. Chan School of Public Health;

Amir Mohareb, assistant director for vaccine equity at the Mass General Hospital Center for Global Health;

William Hanage, associate professor of epidemiology, Harvard T.H. Chan School of Public Health; and

Richard Malley, senior physician in medicine, Division of Infectious Diseases, Boston Children's Hospital, and professor of pediatrics, Harvard Medical School.

This event is part of the Dr. Lawrence H. and Roberta Cohn Forum series. An on-demand video will be posted after the event.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Scott Hensley edits stories about health, biomedical research and pharmaceuticals for NPR's Science desk. During the COVID-19 pandemic, he has led the desk's reporting on the development of vaccines against the coronavirus.